Practice
Clinical updates, guidelines, prescribing, and practical medicine
Pfizer’s Monthly Obesity Drug Shows Promise in Detailed Midstage Trial Data
Detailed midstage trial data provide further evidence that Pfizer's obesity drug berobenatide, acquired from Metsera, could offer effective weight management…
Editor's Top Picks
Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide
Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…
Submit Your Paper →
Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
More form Practice
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…